Emergence of four cases of KPC-2 and KPC-3-carrying Klebsiella pneumoniae introduced to Switzerland, 2009-10

Eurosurveillance

Volumn 16, Issue 11, 2011, Pages

  Babouee, B ^a   Widmer, A F ^a   Dubuis, O ^b   Ciardo, D ^b   Droz, S ^c   Betsch, B Y ^d   Garzoni, C ^d   Fuhrer U ^d   Battegay, M ^a   Frei, R ^a   Goldenberger, D ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Viollier AG   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; COLISTIN; DOXYCYCLINE; FOSFOMYCIN; GENTAMICIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE;

ABDOMINAL BLEEDING; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; BILE DUCT CARCINOMA; BILE DUCT OBSTRUCTION; BLOODSTREAM INFECTION; CASE REPORT; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; CHRONIC OSTEOMYELITIS; DEBRIDEMENT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENDOSCOPIC SURGERY; FEVER; FRACTURE EXTERNAL FIXATION; GASTROINTESTINAL SYMPTOM; GASTROSCOPY; GASTROSTOMY; HUMAN; ITALY; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; MULTIPLE ORGAN FAILURE; OTOTOXICITY; PANCREAS SURGERY; PELVIS ABSCESS; PELVIS FRACTURE; POLYMERASE CHAIN REACTION; STENOSIS; SWITZERLAND;

EID: 79953288404     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/ese.16.11.19817-en     Document Type: Article

References (15)

1. Grundmann H, Livermore DM, Giske CG, Canton R, Rossolini GM, Campos J, et al. Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts. Euro Surveill. 2010;15(46):pii=19711. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19711
2. Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2001;45(4):1151-61.
3. Poirel L, Lienhard R, Potron A, Malinverni R, Siegrist HH, Nordmann P. Plasmid-mediated carbapenem-hydrolysing {beta}-lactamase KPC-2 in a Klebsiella pneumoniae isolate from Switzerland. J Antimicrob Chemother. 2011;66(3):675-6.
4. European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters. Version 1.3, 5 Jan 2011. Available from: http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Disk_test_documents/EUCAST_breakpoints_v1.3_pdf.pdf
5. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing, Twenty-First Informational Supplement M100-S21, Vol. 31, No. 1, January 2011. Wayne: CLSI; 2011.
6. Bradford PA, Bratu S, Urban C, Visalli M, Mariano N, Landman D, et al. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City. Clin Infect Dis. 2004;39(1):55-60.
7. Marschall J, Mühlemann K. Duration of methicillin-resistant Staphylococcus aureus carriage, according to risk factors for acquisition. Infect Control Hosp Epidemiol. 2006;27(11):1206-12.
8. Widmer A.F. Ruef C, Troillet N. Neue Isolationsrichtlinien in den USA für Spitäler und andere Gesundheitseinrichtungen: Bedeutung für die Schweiz. [New isolation guidelines in the US for hospitals and other health institutions: implications for Switzerland]. Swiss-NOSO. 2009;15(1). German. Available from: http://www.chuv.ch/swiss-noso/d151a1.htm
9. Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis. 2009;9(4):228-36.
10. Leavitt A, Navon-Venezia S, Chmelnitsky I, Schwaber MJ, Carmeli Y. Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital. Antimicrob Agents Chemother. 2007;51(8):3026-9.
11. Cuzon G, Naas T, Demachy MC, Nordmann P. Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece. Antimicrob Agents Chemother. 2008;52(2):796-7.
12. Fontana C, Favaro M, Sarmati L, Natoli S, Altieri A, Bossa MC, et al. Emergence of KPC-producing Klebsiella pneumoniae in Italy. BMC Res Notes. 2010;3:40.
13. Giakoupi P, Maltezou H, Polemis M, Pappa O, Saroglou G, Vatopoulos A, et al. KPC-2-producing Klebsiella pneumoniae infections in Greek hospitals are mainly due to a hyperepidemic clone. Euro Surveill. 2009;14(21):pii=19218. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19218
14. Giani T, D'Andrea MM, Pecile P, Borgianni L, Nicoletti P, Tonelli F, et al. Emergence in Italy of Klebsiella pneumoniae sequence type 258 producing KPC-3 carbapenemase. J Clin Microbiol. 2009;47(11):3793-4.
15. Tsakris A, Kristo I, Poulou A, Markou F, Ikonomidis A, Pournaras S. First occurrence of KPC-2-possessing Klebsiella pneumoniae in a Greek hospital and recommendation for detection with boronic acid disc tests. J Antimicrob Chemother. 2008;62(6):1257-60.